In this study, we systematically investigated 61 Chinese female LAM patients focusing on unveiling the landscapes of genetic alterations of TSC1/2 as well non-TSC1/2 in their genomes. The gene discussed is TSC1; the disease is lymphangioleiomyomatosis.